Amgen to Webcast 2011 Business Review Meeting o... ( THOUSAND OAKS Calif. April 14 2011 /-...)

Amgen to Webcast 2011 Business Review Meeting on April 21

Date:4/14/2011

THOUSAND OAKS, Calif., April 14, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced that it will hold its Business Review Meeting on Thursday, April 21, 2011 at the Mandarin Oriental Hotel, 80 Columbus Circle, New York City, beginning at 8 a.m. Eastern Time. In the meeting, Kevin Sharer, chairman and CEO, Robert A. Bradway, president and COO, Roger M. Perlmutter, M.D., Ph.D., executive vice president, Research and Development, and Jonathan M. Peacock, executive vice president and CFO, will discuss the Company's strategy and long-term growth objectives, commercial performance and expectations, research and development innovation and pipeline progress, financial performance expectations and the Company's capital allocation plan.

The webcast will be available to members of the news media, investors and the general public and is expected to last approximately three hours.

The webcast of the meeting, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability, and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay at least 30 days after the event.

About Amgen

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other seri
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program

Post Your Comments:

(Date:5/17/2013)... , May 17, 2013 Orexigen® Therapeutics, Inc. (Nasdaq: ... a company overview at the UBS Global Healthcare Conference in ... for Wednesday, May 22 nd at 11 a.m. Eastern ... of the presentation, please visit the Investor Relations section of ... will be available for 14 days after the event. ...

(Date:5/17/2013)... 17, 2013 Sony Biotechnology Inc. ("Sony") today announced the ... and 130um sorting chip. Sony will also be exhibiting its ... SH800 Cell Sorter, the EC800 flow cytometer, and new SP6800 ... 2013, which will be held at the San ... California , from May 20 - 22. ...

(Date:5/17/2013)... -- Research explores data on treatments ... to be presented Shire ... global specialty biopharmaceutical company, announces that it will present ... Psychiatric Association (APA) 166th Annual Meeting in ... presented represent Shire,s ongoing commitment to the clinical research ...

[0] Orexigen Therapeutics to Present at the UBS Global Healthcare Conference [0] Sony Delivers New Technology for Science to CYTO 2013 [0] Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting

... Ontario, Sept. 2, 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ... members of its senior management team will be participating at ... and Chief Executive Officer will make a presentation at the ... London on Thursday, September 15, 2011 at 10:35 a.m. BT ...

... Lifetime Products, Inc. -- a worldwide Utah-based manufacturer ... storage sheds, and lawn and garden products -- announced ... adding a new Health and Wellness product category. ... will feature products like the award-winning Lifetime Tru-Motion™ ...

Cached Medicine Technology:Lifetime Products Enters New Product Category: Health and Wellness 2

Valeant Pharmaceuticals to Present at Industry Conferences Lifetime Products Enters New Product Category: Health and Wellness

(Date:5/20/2013)... ESMO 32nd ESTRO European Cancer Congress will take ... ), from Friday 17 September to Tuesday 1 October ... The congress will build on the success of the ... Medical Oncology) and ESTRO (European Society for Therapeutic Radiology ... in Europe to offer presentations of cutting-edge research across ...

(Date:5/20/2013)... 2013 Ariosa Diagnostics, maker of the ... syndrome and other chromosome conditions, has announced today the ... conceived or conceived using the patient’s own egg. ... analysis as an option to those women electing to ... the evaluation of fetal sex and sex chromosome genetic ...

(Date:5/20/2013)... Soliant Health, a leading specialty healthcare staffing provider ... its fifth annual Most Beautiful Hospitals in the U.S. contest. ... decided to bypass its routine selection process and include not ... be in the running for the 2013 Most Beautiful Hospitals ... and runs through June 23. Winners will be revealed on ...

(Date:5/20/2013)... Cayman, Cayman Islands (PRWEB) May 20, 2013 ... knowledge-based, high tech Special Economic Zone in the ... Referral Network, an initiative to grow the zone’s ... with Cayman’s business-friendly environment and tax benefits are ... many of them referrals from zone channel partners. ...

(Date:5/20/2013)... Jointly established by The Hong ... (Sichuan U), China's first Institute for Disaster ... officially opened. Both institutions also held the ... Reduction" to conclude lessons learnt from Wenchuan ... Margareta Wahlström, Special Representative of the Secretary-General ...

[0] Media registration for the European Cancer Congress [0] Ariosa Diagnostics Expands Harmony Prenatal Test to Twin Pregnancies and Launches New X,Y Analysis Test [0] Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S.[0] Cayman Enterprise City Introduces Referral Network [0] PolyU and Sichuan U Jointly Set Up China's First Institute for Disaster Management and Reconstruction

... identified a possible cause for the loss of a tumour ... development of more aggressive forms of prostate cancer. , ... prostate cancer develops because we now have some insight into ... Jeremy Squire, a professor in the Department of Pathology and ...

... HPV infection is more common among men than women, explaining ... HPV related head and neck cancer, according to a study ... by AHNS, ASCO, ASTRO and SNM., Human papillomavirus, or HPV, ... neck cancer that are becoming more prominent in the United ...

... or without chemotherapy is less effective for patients with HIV ... patients who do not have HIV, according to a study ... by AHNS, ASCO, ASTRO and SNM. , Treating head and ... Because of the advancements in treating HIV, these patients are ...

... of positron emission tomography/computed tomography (PET/CT) scans in head ... before they become clinically apparent and may improve the ... presented at the Multidisciplinary Head and Neck Cancer Symposium, ... is a relatively new test and its use as ...

... HOUSTON Scientists have connected two signature characteristics of pancreatic ... a new potential target for drugs to treat one of ... in the journal Cancer Cell and led by ... connected the molecular dots between: Mutated versions ...

... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... developing high blood pressure, diabetes or other risk factors for ... attack or stroke by age 80 than their less healthy ... to middle age with an optimal profile, it,s really like ...

Cached Medicine News:Health News:Oral HPV infection, HPV-related cancers more common in men 2 Health News:Standard treatments for head and neck cancer less effective in HIV-positive patients 2 Health News:Mutated Kras spins a molecular loop that launches pancreatic cancer 2 Health News:Mutated Kras spins a molecular loop that launches pancreatic cancer 3 Health News:Optimal Heart Health Starts Early: Study 2 Health News:Optimal Heart Health Starts Early: Study 3

New Queen's University research sheds light on gene destruction linked to aggressive prostate cancer Oral HPV infection, HPV-related cancers more common in men Standard treatments for head and neck cancer less effective in HIV-positive patients Routine follow-up scans can detect head and neck cancer recurrences earlier Mutated Kras spins a molecular loop that launches pancreatic cancer Optimal Heart Health Starts Early: Study

Spetzler titanium microsurgical instrument. Small spatula dissector, bayonet, angled up 30°....

Instrument for transphenoidal hypophysectomy, bayonet-shaped, dissector, sharp inner edge, left....

Cushing-landolt bi-valve speculum for trans-sphenoidal hypophysectomie....

Hardy pituitary spoon, bayonet, malleable....

Medicine Products:

Small Spatula Dissector Hardy Dissector Cushing-Landolt Bi-valve Speculum Hardy Pituitary Spoons